Gonadotropic preparations--lessons learned.

Suppr

超能文献

作者信息

Lunenfeld B, Lunenfeld E

出版信息

Fertil Steril. 1997 May;67(5):812-4. doi: 10.1016/s0015-0282(97)81389-1.

DOI:10.1016/s0015-0282(97)81389-1

PMID:9130882

Abstract

摘要

相似文献

Gonadotropic preparations--lessons learned.

Fertil Steril. 1997 May;67(5):812-4. doi: 10.1016/s0015-0282(97)81389-1.

Early infertility treatments derived from human pituitary.

BMJ. 1993 Apr 24;306(6885):1128-9. doi: 10.1136/bmj.306.6885.1128-b.

[Iatrogenic problems during treatment with gonadotropic hormones].[促性腺激素治疗期间的医源性问题]

Cesk Gynekol. 1968 Feb;33(1):156-9.

The empiric use of gonadotropin therapy and intrauterine insemination.促性腺激素疗法及宫腔内人工授精的经验性应用。

Am J Obstet Gynecol. 1995 Feb;172(2 Pt 2):778-82. doi: 10.1016/0002-9378(95)90153-1.

Recombinant gonadotrophins.重组促性腺激素

Br J Obstet Gynaecol. 1999 Mar;106(3):188-96. doi: 10.1111/j.1471-0528.1999.tb08230.x.

Adjunctive agents in ovulation induction.诱导排卵的辅助药物。

Am J Obstet Gynecol. 1995 Feb;172(2 Pt 2):782-5. doi: 10.1016/0002-9378(95)90154-x.

Ovulation induction in the poor responder or hyperresponder.

Am J Obstet Gynecol. 1995 Feb;172(2 Pt 2):788-91. doi: 10.1016/0002-9378(95)90156-6.

[Characteristics of hypophyseal gonadotropic function in sterility due to internal endometriosis].[内在性子宫内膜异位症所致不育中垂体促性腺功能的特征]

Akush Ginekol (Mosk). 1980 Oct(10):27-9.

[Treatment with gonadotropins in the anovulatory menstrual cycle].[无排卵月经周期的促性腺激素治疗]

Bull Fed Soc Gynecol Obstet Lang Fr. 1961 Oct-Dec;13:618-20.

[Gonadotropins and infertility--a historical overview].[促性腺激素与不孕症——历史概述]

Arch Gynecol Obstet. 1995;257(1-4):87-95. doi: 10.1007/BF02264794.

引用本文的文献

Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis.实现活产所需的重组促卵泡素、高纯度人绝经期促性腺激素和高纯度促卵泡素用量：一项系统评价和荟萃分析。

Hum Reprod Open. 2019 Jun 1;2019(3):hoz008. doi: 10.1093/hropen/hoz008. eCollection 2019.

The Ideal Stimulation Protocol: Is There One?理想的刺激方案：存在这样一种方案吗？

J Obstet Gynaecol India. 2015 Dec;65(6):357-61. doi: 10.1007/s13224-015-0723-8. Epub 2015 Jul 1.

The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction.外源性促黄体生成素（LH）对卵母细胞活力的影响：来自一项比较研究的证据，该研究在垂体抑制的接受辅助生殖的女性中，单独使用重组人促卵泡生成素（FSH）或联合重组LH进行卵巢刺激。

J Assist Reprod Genet. 2001 May;18(5):250-6. doi: 10.1023/a:1016662100572.

Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.在为体外受精而进行垂体抑制后接受卵巢刺激的排卵女性中，给予高纯度或重组促卵泡激素后的卵泡发育和激素水平：对着床潜能的影响

J Assist Reprod Genet. 2000 Jan;17(1):20-7. doi: 10.1023/a:1009493829086.

Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients.在有排卵的女性和世界卫生组织II组无排卵性不孕患者中，给予高纯度或重组促卵泡激素后卵泡发育及激素水平的变化

J Assist Reprod Genet. 1998 Oct;15(9):552-9. doi: 10.1023/a:1022586221077.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验